Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FOSAMAX
- Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
- Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease
- A Multi Center, Randomized, Open-label, Parallel, Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis
- Romosozumab in Women With Chronic SCI
- Comparative Antiresorptive Efficacy Discontinuation of Denosumab
- Bisphosphonates for Prevention of Post-Denosumab Bone Loss
- Denosumab Versus Bisphosphonates (Alendronate) in GIOP
- Pilot Study of Bisphosphonates for Breast Cancer
- Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism
- Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment
- Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss
- 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis
- Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide
- The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults
- RA Denosumab on Bone Microstructure Study
- Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis
- Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
- Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)
- Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis
- Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy
- Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)
- A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)
- Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients
- Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions
- Pilot Study of Fosamax in Spinal Cord Injury
- FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)
- Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)
- Fasting Study of Alendronate Sodium Tablets (10 mg) and Fosamax Tablets (10 mg)
- Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis
- Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents
- Alendronate in Juvenile Osteoporosis
- Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density
- Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.
- Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy
- Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)
- Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects
- Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants
- Glucocorticoids Promote Osteoclast Survival
- Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women
- Upper GI Handling of Branded vs. Generic Alendronate
- Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease
- Fosamax for Childhood Cancer Survivors
- The Effects of Alendronate After Cure of Primary Hyperparathyroidism
- Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation
- Alendronate Osteoporosis Study
- Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis
- Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
- Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )
- Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
- Network Osteoporosis Study
- Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)
- Bisphosphonate Therapy for Osteogenesis Imperfecta
- Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
- Texture Analysis for Postmenopausal Osteoporosis
- Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment
- Vitamin K and Bone Turnover in Postmenopausal Women
- Prevention of Osteoporosis in Men With Prostate Cancer
- Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density
- Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
- Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
- Treatment of Childhood Osteoporosis With Alendronate (Fosamax)
- Osteoporosis Prevention After Heart Transplant
- Alendronate and/or Parathyroid Hormone for Osteoporosis
Clinical trials list
click for details